Joseph A Bardenheir Iii Md is categorized under Family Practice Doctors in Essex, CT and active since 2001.
Joseph A Bardenheir Iii Md was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Joseph Bardenheier at the company’s single location by writing to 3 Wildwood Medical Center, Essex, Connecticut CT 06426 or by phoning (707) 775-4000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Joseph A Bardenheir Iii Md |
| Contact Person: | Joseph Bardenheier |
| Address: | 3 Wildwood Medical Center, Essex, Connecticut 06426 |
| Phone Number: | (707) 775-4000 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Joseph A Bardenheir Iii Md was started in 2001 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Joseph Bardenheier for inquiries that concern Joseph A Bardenheir Iii Md by calling the company number (707) 775-4000, as your correspondence is most welcome. Additionally, the physical location of the single location of Joseph A Bardenheir Iii Md can be found at the coordinates as well as the street address 3 Wildwood Medical Center in Essex, Connecticut 06426.
For its online presence, you may visit Joseph A Bardenheir Iii Md’s website at and engage with its social media outlets through on Twitter and on Facebook.